Prolonged antiviral therapy with peginterferon to prevent complications of advanced liver disease associated with hepatitis C: Results of the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

被引：0
|
作者：
Di Bisceglie, Adrian M.
Shiffman, Mitchell L.
Everson, Gregory T.
Lindsay, Karen L.
Everhart, James E.
Wright, Elizabeth C.
Lee, William M.
Lok, Anna S.
Bonkovsky, Herbert
Morgan, Timothy R.
Dienstag, Jules L.
Ghany, Marc
Morishima, Chihiro
Snow, Kristin K.
机构：
[1] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO 63103 USA
[2] Virginia Commonwealth Univ, Med Ctr, Hepatol Sect, Richmond, VA USA
[3] Univ Colorado, Sch Med, Div Gastroenterol & Hepatol, Sect Hepatol, Denver, CO 80202 USA
[4] Univ So Calif, Keck Sch Med, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA
[5] NIDDKD, Div Digest Dis & Nutr, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[6] NIDDKD, Off Director, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[7] Univ Texas, SW Med Ctr, Div Digest & Liver Dis, Dallas, TX 75230 USA
[8] Univ Michigan, Med Ctr, Div Gastroenterol, Ann Arbor, MI 48109 USA
[9] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA
[10] Univ Connecticut, Ctr Hlth, Dept Mol & Struct Biol, Farmington, CT USA
[11] Univ Connecticut, Ctr Hlth, Liver Biliary Pancreat Ctr, Farmington, CT USA
[12] Univ Calif Irvine, Div Gastroenterol, Irvine, CA USA
[13] Univ Calif Irvine, Gastroenterol Serv, Irvine, CA USA
[14] VA Long Beach Healthcare Syst, Irvine, CA USA
[15] Massachusetts Gen Hosp, Gastrointestinal Unit, Med Serv, Boston, MA 02114 USA
[16] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[17] Harvard Univ, Sch Med, Boston, MA 02115 USA
[18] NIDDKD, Liver Dis Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD USA
[19] Univ Washington, Dept Lab Med, Div Virol, Seattle, WA 98195 USA
[20] New England Res Inst, Watertown, MA 02172 USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LB1
引用
收藏
页码：290A / 290A
页数：1
相关论文
共 50 条
  • [21] Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
    Everhart, James E.
    Lok, Anna S.
    Kim, Hae-Young
    Morgan, Timothy R.
    Lindsay, Karen L.
    Chung, Raymond T.
    Bonkovsky, Herbert L.
    Ghany, Marc G.
    GASTROENTEROLOGY, 2009, 137 (02) : 549 - 557
  • [22] Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial
    Bell, Margaret C.
    Robuck, Patricia R.
    Wright, Elizabeth C.
    Mihova, Marina S.
    Hofmann, Charlotte
    De Santo, Jennifer L.
    Milstein, Susan L.
    Richtmyer, Pamela A.
    Shelton, Janel L.
    Cormier, Maureen
    King, Debra L.
    Park, Choon J.
    Molchen, Wallis A.
    Park, Yoon
    Kelley, Michelle
    CLINICAL TRIALS, 2009, 6 (06) : 618 - 627
  • [23] Ophthalmologic complications of antiviral therapy in hepatitis C treatment
    Roderick O'Day
    Mark C Gillies
    Golo Ahlenstiel
    World Journal of Gastroenterology, 2013, (45) : 8227 - 8237
  • [24] Ophthalmologic complications of antiviral therapy in hepatitis C treatment
    O'Day, Roderick
    Gillies, Mark C.
    Ahlenstiel, Golo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (45) : 8227 - 8237
  • [25] Long-term antiviral treatment for recurrent hepatitis C after liver transplantation
    Bertuzzo, Valentina Rosa
    Cescon, Matteo
    Morelli, Maria Cristina
    Di Gioia, Paolo
    Tame, Mariarosa
    Lorenzini, Stefania
    Andreone, Pietro
    Ercolani, Giorgio
    Del Gaudio, Massimo
    Ravaioli, Matteo
    Cucchetti, Alessandro
    Dazzi, Alessandro
    D'Errico-Grigioni, Antonietta
    Pinna, Antonio Daniele
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (10) : 861 - 867
  • [26] Incidence rates and risk factors associated with hepatocellular carcinoma (HCC) in patients with advanced liver disease due to hepatitis C: Results of the halt-C trial
    Lok, A. S.
    Seeff, L. B.
    Morgan, T. R.
    DiBisceglie, A. M.
    Sterling, R. K.
    Curto, T. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S45 - S45
  • [27] Dietary Cholesterol Intake is Associated with Liver Disease Progression in Hepatitis C Infection: Analysis of the HALT-C trial
    Yu, Lei
    Morishima, Chihiro
    Ioannou, George
    HEPATOLOGY, 2012, 56 : 647A - 648A
  • [28] Prognostic Value of Ishak Fibrosis Stage: Findings from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
    Everhart, James E.
    Wright, Elizabeth C.
    Goodman, Zachary D.
    Dienstag, Jules L.
    Hoefs, John C.
    Kleiner, David E.
    Ghany, Marc G.
    Mills, A. Scott
    Nash, S. Russell
    Govindarajan, Sugantha
    Rogers, Thomas E.
    Greenson, Joel K.
    Brunt, Elizabeth M.
    Bonkovsky, Herbert L.
    Morishima, Chihiro
    Litman, Heather J.
    HEPATOLOGY, 2010, 51 (02) : 585 - 594
  • [29] Treatment of Decompensated Cirrhosis Secondary to Hepatitis C with Antiviral Therapy
    Khokhar, Nasir
    Qureshi, Muhammad Omar
    Niazi, Tariq Khan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2013, 23 (12): : 833 - 836
  • [30] Reversible Myopathy Induced By Long-Term Pegasys Mono Treatment for a Chronic Hepatitis C Patient under HALT-C Trial
    Cai, Chunyu
    Gioaccotto, Josh
    Felice, Kevin
    Grunnet, Margaret
    Whitaker, Charles
    Wu, Qian
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 580 - 580
12345